George J. Bosl

20.6k total citations · 1 hit paper
330 papers, 14.2k citations indexed

About

George J. Bosl is a scholar working on Surgery, Neurology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, George J. Bosl has authored 330 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 281 papers in Surgery, 102 papers in Neurology and 96 papers in Pulmonary and Respiratory Medicine. Recurrent topics in George J. Bosl's work include Testicular diseases and treatments (259 papers), Neuroblastoma Research and Treatments (99 papers) and Sarcoma Diagnosis and Treatment (80 papers). George J. Bosl is often cited by papers focused on Testicular diseases and treatments (259 papers), Neuroblastoma Research and Treatments (99 papers) and Sarcoma Diagnosis and Treatment (80 papers). George J. Bosl collaborates with scholars based in United States, Spain and Russia. George J. Bosl's co-authors include Robert J. Motzer, Dean F. Bajorin, Joel Sheinfeld, Victor E. Reuter, R. S. K. Chaganti, Jane Houldsworth, Nancy L. Geller, Jennifer Bacik, Madhu Mazumdar and Harry W. Herr and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

George J. Bosl

326 papers receiving 13.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Testicular Germ-Cell Cancer

1997 645 citations George J. Bosl, Robert J. Motzer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George J. Bosl United States	68	10.6k	4.1k	3.8k	3.5k	2.6k	330	14.2k
David M. Gershenson United States	76	5.9k 0.6×	4.2k 1.0×	2.5k 0.7×	483 0.1×	12.0k 4.6×	406	21.6k
Silvana Pilotti Italy	68	2.7k 0.3×	5.1k 1.2×	5.3k 1.4×	1.3k 0.4×	375 0.1×	294	16.2k
Suzanne George United States	55	2.1k 0.2×	1.8k 0.4×	6.8k 1.8×	1.4k 0.4×	541 0.2×	257	11.7k
Manisha H. Shah United States	53	2.4k 0.2×	4.3k 1.0×	3.3k 0.9×	3.1k 0.9×	184 0.1×	203	18.0k
Martee L. Hensley United States	55	1.6k 0.2×	1.8k 0.4×	4.7k 1.2×	244 0.1×	3.8k 1.4×	223	13.3k
Antoîne Italiano France	67	2.6k 0.2×	4.0k 1.0×	9.2k 2.4×	831 0.2×	377 0.1×	618	17.5k
Terry L. Smith United States	65	1.8k 0.2×	2.8k 0.7×	2.6k 0.7×	514 0.1×	446 0.2×	154	16.0k
Paul Elson United States	60	3.2k 0.3×	4.5k 1.1×	5.6k 1.5×	397 0.1×	354 0.1×	334	13.4k
Alberto S. Pappo United States	60	2.4k 0.2×	2.4k 0.6×	6.7k 1.8×	1.9k 0.6×	105 0.0×	308	11.6k
Margaret von Mehren United States	55	5.0k 0.5×	2.2k 0.5×	10.7k 2.8×	2.4k 0.7×	140 0.1×	282	16.3k

Countries citing papers authored by George J. Bosl

Since Specialization

Citations

This map shows the geographic impact of George J. Bosl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George J. Bosl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George J. Bosl more than expected).

Fields of papers citing papers by George J. Bosl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George J. Bosl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George J. Bosl. The network helps show where George J. Bosl may publish in the future.

Co-authorship network of co-authors of George J. Bosl

This figure shows the co-authorship network connecting the top 25 collaborators of George J. Bosl. A scholar is included among the top collaborators of George J. Bosl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George J. Bosl. George J. Bosl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Knežević, Andrea, Sujata Patil, Joel Sheinfeld, et al.. (2024). Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease. Journal of Clinical Oncology. 42(26). 3130–3139. 4 indexed citations

Thodima, Venkata J., et al.. (2014). miR-18b and miR-518b Target FOXN1 During Epithelial Lineage Differentiation in Pluripotent Cells. Stem Cells and Development. 23(10). 1149–1156. 11 indexed citations

Feldman, Darren R., Walter M. Stadler, Leonard J. Appleman, et al.. (2014). Multicenter sequential phase II study of flavopiridol plus oxaliplatin (Alvocidib) with or without 5-FU and leucovorin (LV) for patients (pts) with refractory germ cell tumors (GCT) including late relapse (LR).. Journal of Clinical Oncology. 32(4_suppl). 364–364. 2 indexed citations

Feldman, Darren R., Joel Sheinfeld, Dean F. Bajorin, et al.. (2010). TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis. Journal of Clinical Oncology. 28(10). 1706–1713. 147 indexed citations

Feldman, Darren R. & George J. Bosl. (2008). Treatment of stage I seminoma: is it time to change your practice?. Journal of Hematology & Oncology. 1(1). 22–22. 8 indexed citations

Korkola, James E., Jane Houldsworth, Rajendrakumar S.V. Chadalavada, et al.. (2006). Down-Regulation of Stem Cell Genes, Including Those in a 200-kb Gene Cluster at 12p13.31, Is Associated with In vivo Differentiation of Human Male Germ Cell Tumors. Cancer Research. 66(2). 820–827. 236 indexed citations

Korkola, James E., Jane Houldsworth, Adam B. Olshen, et al.. (2005). Gene expression-based classification of nonseminomatous male germ cell tumors. Oncogene. 24(32). 5101–5107. 49 indexed citations

Rabbani, Farhang, Joel Sheinfeld, Hesam Farivar-Mohseni, et al.. (2001). Low-Volume Nodal Metastases Detected at Retroperitoneal Lymphadenectomy for Testicular Cancer: Pattern and Prognostic Factors for Relapse. Journal of Clinical Oncology. 19(7). 2020–2025. 61 indexed citations

Xiao, Han, David Liu, Dean F. Bajorin, Michael Burt, & George J. Bosl. (1998). MEDICAL AND SURGICAL MANAGEMENT OF PULMONARY METASTASES FROM GERM CELL TUMORS. Chest Surgery Clinics of North America. 8(1). 131–144. 6 indexed citations

10.

Murphy, Barbara A., Robert J. Motzer, Madhu Mazumdar, et al.. (1994). Serum tumor marker decline is an early predictor of treatment outcome in germ cell tumor patients treated with cisplatin and ifosfamide salvage chemotherapy. Cancer. 73(10). 2520–2526. 42 indexed citations

11.

Pfister, David G., Dean F. Bajorin, Robert J. Motzer, et al.. (1993). A phase II trial of deoxyspergualin in recurrent squamous cell head and neck cancer. Investigational New Drugs. 11(1). 53–56. 1 indexed citations

12.

Motzer, Robert J., Madhu Mazumdar, Subhash C. Gulati, et al.. (1993). Phase II Trial of High-Dose Carboplatin and Etoposide With Autologous Bone Marrow Transplantation in First-Line Therapy for Patients With Poor-Risk Germ Cell Tumors. JNCI Journal of the National Cancer Institute. 85(22). 1828–1835. 112 indexed citations

13.

Gastl, Guenther, Connie L. Finstad, Anna Guarini, et al.. (1992). Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.. PubMed. 52(22). 6229–36. 63 indexed citations

14.

Bajorin, Dean F., et al.. (1991). Two-drug therapy in patients with metastatic germ cell tumors. Cancer. 67(1). 28–32. 24 indexed citations

15.

Nanus, David M. & George J. Bosl. (1989). Systemic chemotherapy in the management of bladder cancer. Cancer treatment and research. 46. 143–158. 1 indexed citations

16.

Bosl, George J., Nancy L. Geller, N. Vogelzang, et al.. (1987). Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors.. Journal of Clinical Oncology. 5(3). 436–440. 57 indexed citations

17.

Kris, Mark G., Richard J. Gralla, Leslie B. Tyson, et al.. (1985). Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients. Cancer. 55(3). 527–534. 154 indexed citations

18.

Bosl, George J., Nancy L. Geller, Constance Cirrincione, et al.. (1983). Serum tumor markers in patients with metastatic germ cell tumors of the testis. The American Journal of Medicine. 75(1). 29–35. 49 indexed citations

19.

Bosl, George J., Anne I. Goldman, P.H. Lange, et al.. (1981). IMPACT OF DELAY IN DIAGNOSIS ON CLINICAL STAGE OF TESTICULAR CANCER. The Lancet. 318(8253). 970–973. 116 indexed citations

20.

Bosl, George J., Paul H. Lange, Lucien E. Nochomovitz, et al.. (1981). Tumor markers in advanced nonseminomatous testicular cancer. Cancer. 47(3). 572–576. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact